Search clinical trials for: PELOD-2 score

Total 50462 results

University of Birmingham
University College, London; National Institute for Health Research, United...

Recruiting

ROSSINI 2 - Reduction of Surgical Site Infection Using Several Novel Interventions (ROSSINI 2)

Surgery | Surgery--Complications | Surgical Wound Infection | Surgical Site Infection

United Kingdom
Eyenovia Inc.

Completed

Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults (VISION-2)

Presbyopia

United States
Istanbul University - Cerrahpasa (IUC)

Recruiting

Turkish Adaptation and Psychometric Properties of Fugl-Meyer Assessment in Acute Stroke Patients (FMD)

Stroke, Acute | Cerebrovascular; Disorder, Acute

Turkey
Sanofi Pasteur, a Sanofi Company

Completed

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23

Influenza (Healthy Volunteers)

Germany, Finland
Eastern Mediterranean University

Not yet recruiting

The Effect of Health Education and Yoga on Menopause Symptoms and Quality of Life According to Pender's Model

Quality of Life | Health Education | Yoga | Menopause Symptoms

Cyprus
Eastern Mediterranean University

Not yet recruiting

Effect of Acupressure on Pain, Anxiety and Vital Signs in Patients With Coronary Angiography

Pain | Anxiety | Coronary Angiography | Vital Signs

Cyprus
Kirsehir Ahi Evran Universitesi

Not yet recruiting

Supportive Care Training Given to Mothers of Babies With Infants Colic

Infantile Colic | Mothers

Turkey
Acibadem Fulya Hastanesi

Unknown

Ovarian Functions in Flight Attendants

Ovarian Functions in Flight Attendants

Turkey
Changzhou No.2 People's Hospital

Not yet recruiting

FMT+SOX+Sintilimab as First-line Treatment for Advanced Gastric Cancer

Gastric Cancer
Changzhou No.2 People's Hospital

Not yet recruiting

An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple Myeloma

Multiple Myeloma

China
Azienda Ulss 2 Marca Trevigiana

Enrolling by invitation

POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as a Prognostic Factor. Participants Are Women >= 18 Years Old, With the Pole Mutation (POLE-END)

Endometrial Neoplasms

Italy
Bond Avillion 2 Development LP

Completed

To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years. (BLANC)

Asthma

United States
Changzhou No.2 People's Hospital

Unknown

Apatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic Cancer (ASPC)

Advanced Pancreatic Cancer
XuanwuH 2

Completed

Construction of Diagnosis System for Early AD Based on Multi-Modality MRI Technology

Mild Cognitive Impairment | Alzheimer's Disease

China
Changzhou No.2 People's Hospital

Unknown

Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer

Esophageal Cancer

China
Tianjin Medical University Second Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor

Solid Tumor | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein Overexpression

China
PowderMed

Completed

A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects

HSV-2

United States
Merrion Fertility Clinic
University College Dublin

Unknown

Cervical Mucus - the Biochemical and Molecular Properties in Fertile and Subfertile Women (C-MIS Study) (C-MIS)

Infertility

Ireland
Bond Avillion 2 Development LP

Completed

A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma (MANDALA)

Asthma

United States, Canada, Germany, Spain, South Africa, United Kingdom, Slovakia, Argentina, Ukraine, Serbia, Czechia
XuanwuH 2
Xuanwu Hospital, Beijing

Completed

Multi-modality MRI Study on Differences in Conversion of aMCI Patients With APOEε4 to AD

Mild Cognitive Impairment

China
Azienda Sanitaria ASL Avellino 2

Unknown

Effects of Short-chain Fatty Acids on Inflammatory and Metabolic Parameters in Maintenance Hemodialysis (PLAN)

Endstage Renal Disease
Azienda Sanitaria ASL Avellino 2

Unknown

Renal Effects of Meditarranean Diet and Low-protein Diet With Ketoacids on Physiological Intestinal Mibrobiota in CKD (MEDIKA)

Chronic Renal Insufficiency

Italy
Université Victor Segalen Bordeaux 2

Completed

Tracheal Dosage of Amylase : a New Surrogate for Microaspirations in Ventilated ICU Patients

Ventilated-acquired Pneumonia

France
Azienda Sanitaria ASL Avellino 2

Unknown

Correction of Metabolic Acidosis in End Stage Renal Disease (ESRD) (UBI)

Metabolic Acidosis

Italy
Université Victor Segalen Bordeaux 2

Completed

Acute Kidney Injury in Septic Critically Ill Patients : Are Aminoglycosides Really Harmful? (REAMICHOC)

Acute Kidney Injury | Severe Sepsis

France
Sanofi Pasteur, a Sanofi Company

Completed

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2021/22

Influenza (Healthy Volunteers)

Germany, Finland
Novavax
Coalition for Epidemic Preparedness Innovations

Completed

Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant

COVID-19

United States, Australia
Argorna Pharmaceuticals Co., LTD

Completed

Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster

SARS-CoV-2

China
Argorna Pharmaceuticals Co., LTD

Completed

A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults

SARS-CoV-2

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Active, not recruiting

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years.

SARS-CoV-2

China
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Active, not recruiting

A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China

SARS-CoV-2

China
Arcturus Therapeutics, Inc.

Terminated

Open Label Extension Study to Assess the Safety and Long-Term Immunogenicity of ARCT-021

SARS-CoV-2

Singapore
University Hospital Inselspital, Berne
University of Bern; Lucerne University of Applied Sciences and Arts

Completed

Understanding Potential Airborne Transmission and the Protective Value of Type II Surgical Masks in SARS-CoV-2 (aeroCOVID1)

SARS-CoV-2

Switzerland
Centre Hospitalier Universitaire Dijon

Unknown

Prognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2 (CodePRONUT)

SARS-CoV-2

France
Meshalkin Research Institute of Pathology of Circulation

Unknown

SARS-CoV-2 Disguise Study (Disguise)

Sars-CoV2

Russian Federation
CytRx

Withdrawn

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

Amyotrophic Lateral Sclerosis

United States, Canada
AIM Vaccine Co., Ltd.
Zhejiang Provincial Center for Disease Control and Prevention

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)

SARS-CoV-2

China
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Not yet recruiting

A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chinese People

SARS-CoV-2
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College

Active, not recruiting

A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)

SARS-CoV-2

China
AIM Vaccine Co., Ltd.
Hunan Provincial Center for Disease Control and Prevention

Completed

Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People

SARS-CoV-2

China
Indiana University

Completed

Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers (COVID-Antibody)

SARS-CoV-2

United States
Peking University
Centers for Disease Control and Prevention, China; Beijing Pinggu District... and other collaborators

Completed

Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 2)

SARS-CoV-2

China
Assistance Publique - Hôpitaux de Paris

Completed

NOsocomial Dissemination Risk of SARS-Cov2 (NODS-Cov2)

Sars-CoV2

France
University Hospital, Montpellier
societe SkillCell - 97198 Jarry; CNRS Alcediag UMR9005 - societe Sys2Diag -...

Completed

Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2 (EasyCoV)

SARS-CoV-2

France
Tongue Laboratory

Unknown

Efficacy Study of the Medical Device TRP Snorless™ in the Treatment of Snoring (SCORED)

Snoring

Czechia
Changzhou No.2 People's Hospital

Not yet recruiting

γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors

Advanced Solid Tumor
Changzhou No.2 People's Hospital

Not yet recruiting

FMT+Immunotherapy+Chemotherapy as First-line Treatment for Driver-gene Negative Advanced NSCLC

Non-small Cell Lung Cancer
Wuxi No. 2 People's Hospital

Active, not recruiting

Construction and Validation of a Postoperative Self-management Education Program for Elderly Patients With Enterostomies

Elderly | Education | Self-management | Enterostomy

China
XuanwuH 2

Completed

Prediction of Cognitive Decline by Neuroimaging Techniques and the Application in Diagnosis and Treatment of Preclinical AD

Subjective Cognitive Decline | Preclinical Alzheimer's Disease

China
Bond Avillion 2 Development LP

Completed

A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma (DENALI)

Asthma

United States, Germany, Ukraine, Serbia, Czechia, Argentina, Slovakia

3

Subscribe